Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for its amycretin weight-loss drug.

A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the competitive field.

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk's blockbuster weight-loss drug Wegovy. Here's

Trump added Denmark to his growing list of tariff targets — including Canada, Mexico and China — as he has increasingly spoken of the U.S. taking Greenland off Denmark’s hands. Danish multinational pharmaceutical giant Novo Nordisk is the sole owner ...

Novo Nordisk is facing serious pressure from a powerful adversary. It still has plenty of leeway to penetrate its target market, for now. Investors should keep a close eye on this company.

Mads Krogsgaard Thomsen, CEO of Novo Nordisk Foundation, discusses European competitiveness.

(Reuters) - European shares were subdued on Tuesday, as rising financials and healthcare shares countered broader losses stemming from uncertainty related to U.S. President Donald Trump's proposed tariff measures following his inauguration. The pan-European STOXX 600 was up 0.1% as of 0954 GMT, hovering near its highest in three months.

By Nikhil Sharma and Pranav Kashyap (Reuters) -European shares rose on Tuesday, buoyed by gains in the healthcare and luxury sectors, but the uptick was tempered by lingering uncertainties over U.S. President Donald Trump's proposed tariff measures following his inauguration.

US stocks subdued at open, but S&P 500 inches up to a record high for third straight day. As tariff worries ease for now, company news takes focus.

Canada's main stock index opened slightly higher on Friday as mining stocks added support, but losses in industrials shares limited gains. The TSX index dipped 0.04 points to start Friday at 25,434.04.

Canada's main stock index was subdued on Friday after eight successive winning sessions as falling energy stocks offset gains elsewhere. The TSX index dipped 0.04 points to start Friday at 25,434.04.

Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's largest healthcare company, with a market cap that topped $8